Literature DB >> 19091975

Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.

Thomas L Kash1, William P Nobis, Robert T Matthews, Danny G Winder.   

Abstract

A common feature of drugs of abuse is their ability to increase extracellular dopamine levels in key brain circuits. The actions of dopamine within these circuits are thought to be important in reward and addiction-related behaviors. Current theories of addiction also posit a central role for corticotrophin-releasing factor (CRF) and an interaction between CRF and monoaminergic signaling. One region where drugs of abuse promote robust rises in extracellular dopamine levels is the bed nucleus of the stria terminalis (BNST), a CRF-rich component of the extended amygdala. We find that dopamine rapidly enhances glutamatergic transmission in the BNST through activation of a combination of D(1)- and D(2)-like receptors. This enhancement is activity-dependent and requires the downstream action of CRF receptor 1 (CRF-R1), suggesting that dopamine induces CRF release through a local network mechanism. Furthermore, we found that both in vivo and ex vivo cocaine induced a dopamine receptor and CRF-R1-dependent enhancement of a form of NMDA receptor-dependent short-term potentiation in the BNST. These data highlight a direct and rapid interaction between dopamine and CRF systems that regulates excitatory transmission and plasticity in a brain region key to reinforcement and reinstatement. Because a rise in extracellular dopamine levels in the BNST is a shared consequence of multiple classes of drugs of abuse, this suggests that the CRF-R1-dependent enhancement of glutamatergic transmission in this region may be a common key feature of substances of abuse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091975      PMCID: PMC2630395          DOI: 10.1523/JNEUROSCI.4715-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

Review 1.  Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety.

Authors:  David L Walker; Donna J Toufexis; Michael Davis
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

2.  Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis.

Authors:  Hong-Wei Dong; Larry W Swanson
Journal:  J Comp Neurol       Date:  2004-01-06       Impact factor: 3.215

3.  Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis.

Authors:  Regula E Egli; Danny G Winder
Journal:  J Neurophysiol       Date:  2003-03-20       Impact factor: 2.714

4.  High-frequency stimulation induces ethanol-sensitive long-term potentiation at glutamatergic synapses in the dorsolateral bed nucleus of the stria terminalis.

Authors:  Carl Weitlauf; Regula E Egli; Brad A Grueter; Danny G Winder
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

5.  Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning.

Authors:  Thomas Blank; Ingrid Nijholt; Klaus Eckart; Joachim Spiess
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

6.  Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits.

Authors:  F Woodward Hopf; Maria Grazia Cascini; Adrienne S Gordon; Ivan Diamond; Antonello Bonci
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

7.  Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.

Authors:  Emmanuel Valjent; Christiane Pagès; Denis Hervé; Jean-Antoine Girault; Jocelyne Caboche
Journal:  Eur J Neurosci       Date:  2004-04       Impact factor: 3.386

8.  Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.

Authors:  Jie Liu; Baojian Yu; Volker Neugebauer; Dimitri E Grigoriadis; Jean Rivier; Wylie W Vale; Patricia Shinnick-Gallagher; Joel P Gallagher
Journal:  J Neurosci       Date:  2004-04-21       Impact factor: 6.167

9.  Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors.

Authors:  Zhiguo Nie; Paul Schweitzer; Amanda J Roberts; Samuel G Madamba; Scott D Moore; George Robert Siggins
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

10.  Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons.

Authors:  Mark A Ungless; Vineeta Singh; Tara L Crowder; Rami Yaka; Dorit Ron; Antonello Bonci
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

View more
  71 in total

1.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

2.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

3.  Contrasting distribution of physiological cell types in different regions of the bed nucleus of the stria terminalis.

Authors:  Olga E Rodríguez-Sierra; Hjalmar K Turesson; Denis Pare
Journal:  J Neurophysiol       Date:  2013-08-07       Impact factor: 2.714

4.  Synaptic Plasticity in the Bed Nucleus of the Stria Terminalis: Underlying Mechanisms and Potential Ramifications for Reinstatement of Drug- and Alcohol-Seeking Behaviors.

Authors:  Nicholas A Harris; Danny G Winder
Journal:  ACS Chem Neurosci       Date:  2018-06-13       Impact factor: 4.418

5.  Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis.

Authors:  Michal Krawczyk; François Georges; Robyn Sharma; Xenos Mason; Amandine Berthet; Erwan Bézard; Eric C Dumont
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

6.  A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.

Authors:  Matthew B Pomrenze; Jorge Tovar-Diaz; Angelo Blasio; Rajani Maiya; Simone M Giovanetti; Kelly Lei; Hitoshi Morikawa; F Woodward Hopf; Robert O Messing
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

7.  A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis.

Authors:  Yuval Silberman; Robert T Matthews; Danny G Winder
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 8.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

9.  Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis.

Authors:  J-D Guo; D G Rainnie
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

10.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.